BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nakanuma Y, Tsuneyama K, Ohbu M, Katayanagi K. Pathology and pathogenesis of idiopathic portal hypertension with an emphasis on the liver. Pathol Res Pract. 2001;197:65-76. [PMID: 11261820 DOI: 10.1078/0344-0338-5710012] [Cited by in Crossref: 75] [Cited by in F6Publishing: 51] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Sato Y, Sawada S, Nakanuma Y. Fibulin-5 is involved in phlebosclerosis of major portal vein branches associated with elastic fiber deposition in idiopathic portal hypertension. Hepatol Res 2008;38:166-73. [PMID: 18197878 DOI: 10.1111/j.1872-034X.2007.00253.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
2 Nicoară-Farcău O, Rusu I, Stefănescu H, Tanțău M, Badea RI, Procopeț B. Diagnostic challenges in non-cirrhotic portal hypertension - porto sinusoidal vascular disease. World J Gastroenterol 2020;26:3000-11. [PMID: 32587444 DOI: 10.3748/wjg.v26.i22.3000] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Goel A, Elias JE, Eapen CE, Ramakrishna B, Elias E. Idiopathic Non-Cirrhotic Intrahepatic Portal Hypertension (NCIPH)-Newer Insights into Pathogenesis and Emerging Newer Treatment Options. J Clin Exp Hepatol. 2014;4:247-256. [PMID: 25755567 DOI: 10.1016/j.jceh.2014.07.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
4 Chang PE, Miquel R, Blanco JL, Laguno M, Bruguera M, Abraldes JG, Bosch J, Garcia-Pagan JC. Idiopathic portal hypertension in patients with HIV infection treated with highly active antiretroviral therapy. Am J Gastroenterol. 2009;104:1707-1714. [PMID: 19471257 DOI: 10.1038/ajg.2009.165] [Cited by in Crossref: 62] [Cited by in F6Publishing: 47] [Article Influence: 5.2] [Reference Citation Analysis]
5 Kobayashi S, Matsui O, Gabata T, Sanada J, Koda W, Minami T, Ryu Y. Radiological and histopathological manifestations of hepatocellular nodular lesions concomitant with various congenital and acquired hepatic hemodynamic abnormalities. Jpn J Radiol 2009;27:53-68. [PMID: 19373534 DOI: 10.1007/s11604-008-0299-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
6 Nemcek AA, Yakes W. SIR 2005 Annual Meeting Film Panel case: inferior mesenteric artery-to-inferior mesenteric vein fistulous connection. J Vasc Interv Radiol. 2005;16:1179-1182. [PMID: 16151057 DOI: 10.1097/01.rvi.0000175327.10770.40] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
7 Harmanci O, Buyukasik Y, Kirazli S, Balkanci F, Bayraktar Y. Does endothelium agree with the concept of idiopathic hepatic vessel thrombosis? World J Gastroenterol 2006;12:1273-7. [PMID: 16534884 DOI: 10.3748/wjg.v12.i8.1273] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
8 Berzigotti A, Magalotti D, Zappoli P, Rossi C, Callea F, Zoli M. Peliosis hepatis as an early histological finding in idiopathic portal hypertension: A case report. World J Gastroenterol. 2006;12:3612-3615. [PMID: 16773721 DOI: 10.3748/wjg.v12.i22.3612] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
9 Tsuneyama K, Kouda W, Nakanuma Y. Portal and Parenchymal Alterations of the Liver in Idiopathic Portal Hypertension: A Histological and Immunochemical Study. Pathology - Research and Practice 2002;198:597-603. [DOI: 10.1078/0344-0338-00308] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
10 Harmanci O, Bayraktar Y. Clinical characteristics of idiopathic portal hypertension. World J Gastroenterol. 2007;13:1906-1911. [PMID: 17461489 DOI: 10.3748/wjg.v13.i13.1906] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
11 Sarin SK, Kumar A, Chawla YK, Baijal SS, Dhiman RK, Jafri W, Lesmana LA, Guha Mazumder D, Omata M, Qureshi H, Raza RM, Sahni P, Sakhuja P, Salih M, Santra A, Sharma BC, Sharma P, Shiha G, Sollano J; Members of the APASL Working Party on Portal Hypertension. Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment. Hepatol Int 2007;1:398-413. [PMID: 19669336 DOI: 10.1007/s12072-007-9010-9] [Cited by in Crossref: 105] [Cited by in F6Publishing: 64] [Article Influence: 7.5] [Reference Citation Analysis]
12 Okuda K. Non-cirrhotic portal hypertension: why is it so common in India. J Gastroenterol Hepatol. 2002;17:1-5. [PMID: 11895548 DOI: 10.1046/j.1440-1746.2002.02660.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
13 Ueda T, Starkey J, Mori K, Fukunaga K, Shimofusa R, Motoori K, Minami M, Kondo F. A pictorial review of benign hepatocellular nodular lesions: comprehensive radiological assessment incorporating the concept of anomalous portal tract syndrome. Journal of Hepato-Biliary-Pancreatic Sciences 2011;18:386-96. [DOI: 10.1007/s00534-010-0342-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
14 Iida H, Osaki R, Matsubara A, Maehira H, Mori H, Fujimoto T, Andoh A, Kushima R, Nakashima O, Kondo F, Tani M. Two cases of benign hepatic nodules caused by sinusoidal dilatation with different hemodynamics. Clin J Gastroenterol 2020;13:873-81. [PMID: 32418022 DOI: 10.1007/s12328-020-01129-0] [Reference Citation Analysis]
15 Tantemsapya N, Superina R, Wang D, Kronauer G, Whitington PF, Melin-aldana H. Hepatic Histology and Morphometric Measurements in Idiopathic Extrahepatic Portal Vein Thrombosis in Children, Correlated to Clinical Outcome of Meso-Rex Bypass. Annals of Surgery 2018;267:1179-84. [DOI: 10.1097/sla.0000000000002128] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Khanna R, Sarin SK. Noncirrhotic Portal Hypertension: Current and Emerging Perspectives. Clin Liver Dis. 2019;23:781-807. [PMID: 31563222 DOI: 10.1016/j.cld.2019.07.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
17 Paley EL. Discovery of Gut Bacteria Specific to Alzheimer's Associated Diseases is a Clue to Understanding Disease Etiology: Meta-Analysis of Population-Based Data on Human Gut Metagenomics and Metabolomics. J Alzheimers Dis 2019;72:319-55. [PMID: 31561379 DOI: 10.3233/JAD-190873] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
18 Sarin SK, Khanna R. Non-cirrhotic Portal Hypertension. Clinics in Liver Disease 2014;18:451-76. [DOI: 10.1016/j.cld.2014.01.009] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 6.1] [Reference Citation Analysis]
19 Hübscher SG. Pathology of non-cirrhotic portal hypertension and incomplete septal cirrhosis. Diagnostic Histopathology 2011;17:530-8. [DOI: 10.1016/j.mpdhp.2011.10.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
20 Krasinskas AM, Eghtesad B, Kamath PS, Demetris AJ, Abraham SC. Liver transplantation for severe intrahepatic noncirrhotic portal hypertension. Liver Transpl 2005;11:627-34. [DOI: 10.1002/lt.20431] [Cited by in Crossref: 109] [Cited by in F6Publishing: 80] [Article Influence: 6.8] [Reference Citation Analysis]
21 Nakanuma Y, Sato Y, Kiktao A. Pathology and pathogenesis of portal venopathy in idiopathic portal hypertension: Hints from systemic sclerosis. Hepatology Research 2009;39:1023-31. [DOI: 10.1111/j.1872-034x.2009.00555.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
22 Tanaka T, Sugawara Y, Kokudo N. The current clinical aspects of idiopathic portal hypertension. Intractable Rare Dis Res. 2013;2:94-97. [PMID: 25343110 DOI: 10.5582/irdr.2013.v2.3.94] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
23 Kitao A, Sato Y, Sawada-Kitamura S, Harada K, Sasaki M, Morikawa H, Shiomi S, Honda M, Matsui O, Nakanuma Y. Endothelial to mesenchymal transition via transforming growth factor-beta1/Smad activation is associated with portal venous stenosis in idiopathic portal hypertension. Am J Pathol 2009;175:616-26. [PMID: 19608867 DOI: 10.2353/ajpath.2009.081061] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 5.4] [Reference Citation Analysis]
24 Chouraqui E, Leguilloux L, Dohan A, Gouya H, Barral M, Vallet-Pichard A, Sogni P, Pol S, Mallet V, Soyer P. Can we differentiate HIV-associated obliterative portopathy from liver cirrhosis using MRI? Eur Radiol 2020;30:213-23. [PMID: 31410601 DOI: 10.1007/s00330-019-06391-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
25 Bayan K, Tüzün Y, Yılmaz Ş, Canoruc N, Dursun M. Analysis of inherited thrombophilic mutations and natural anticoagulant deficiency in patients with idiopathic portal hypertension. J Thromb Thrombolysis 2009;28:57-62. [DOI: 10.1007/s11239-008-0244-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
26 Jha P, Poder L, Wang ZJ, Westphalen AC, Yeh BM, Coakley FV. Radiologic mimics of cirrhosis. AJR Am J Roentgenol. 2010;194:993-999. [PMID: 20308502 DOI: 10.2214/AJR.09.3409] [Cited by in Crossref: 38] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
27 Tsuneyama K, Ohba K, Zen Y, Sato Y, Niwa H, Minato H, Nakanuma Y. A comparative histological and morphometric study of vascular changes in idiopathic portal hypertension and alcoholic fibrosis/cirrhosis. Histopathology. 2003;43:55-61. [PMID: 12823713 DOI: 10.1046/j.1365-2559.2003.01658.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
28 Seijo S, Lozano JJ, Alonso C, Miquel R, Berzigotti A, Reverter E, Turon F, Martínez-chantar ML, Castro A, Mato JM, Hernández-gea V, Bosch J, García-pagán JC. Metabolomics as a diagnostic tool for idiopathic non-cirrhotic portal hypertension. Liver Int 2016;36:1051-8. [DOI: 10.1111/liv.12972] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
29 Wang T, Zhao X, Shao C, Ye L, Guo J, Peng N, Zhang H, Li J, Kong Y, You H, Jia J. A proposed pathologic sub-classification of drug-induced liver injury. Hepatol Int 2019;13:339-51. [PMID: 30977034 DOI: 10.1007/s12072-019-09940-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Khanna R, Sarin SK. Non-cirrhotic portal hypertension - diagnosis and management. J Hepatol. 2014;60:421-441. [PMID: 23978714 DOI: 10.1016/j.jhep.2013.08.013] [Cited by in Crossref: 170] [Cited by in F6Publishing: 100] [Article Influence: 21.3] [Reference Citation Analysis]
31 Seijo S, Reverter E, Miquel R, Berzigotti A, Abraldes JG, Bosch J, García-Pagán JC. Role of hepatic vein catheterisation and transient elastography in the diagnosis of idiopathic portal hypertension. Dig Liver Dis. 2012;44:855-860. [PMID: 22721839 DOI: 10.1016/j.dld.2012.05.005] [Cited by in Crossref: 75] [Cited by in F6Publishing: 49] [Article Influence: 8.3] [Reference Citation Analysis]
32 Sato Y, Ren XS, Harada K, Sasaki M, Morikawa H, Shiomi S, Honda M, Kaneko S, Nakanuma Y. Induction of elastin expression in vascular endothelial cells relates to hepatoportal sclerosis in idiopathic portal hypertension: possible link to serum anti-endothelial cell antibodies. Clin Exp Immunol. 2012;167:532-542. [PMID: 22288597 DOI: 10.1111/j.1365-2249.2011.04530.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
33 Guido M, Alves VAF, Balabaud C, Bathal PS, Bioulac-sage P, Colombari R, Crawford JM, Dhillon AP, Ferrell LD, Gill RM, Hytiroglou P, Nakanuma Y, Paradis V, Quaglia A, Rautou PE, Theise ND, Thung S, Tsui WMS, Sempoux C, Snover D, van Leeuwen DJ; The International Liver Pathology Study Group. Histology of portal vascular changes associated with idiopathic non-cirrhotic portal hypertension: nomenclature and definition. Histopathology 2019;74:219-26. [DOI: 10.1111/his.13738] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
34 Gibbs JF, Litwin AM, Kahlenberg MS. Contemporary management of benign liver tumors. Surg Clin North Am. 2004;84:463-480. [PMID: 15062656 DOI: 10.1016/j.suc.2003.11.003] [Cited by in Crossref: 33] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
35 Okuda K. Non-cirrhotic portal hypertension versus idiopathic portal hypertension. J Gastroenterol Hepatol. 2002;17 Suppl 3:S204-S213. [PMID: 12472938 DOI: 10.1046/j.1440-1746.17.s3.2.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
36 Nakanuma Y, Kouda W, Nakano T, Uneno K, Tachibana S, Araki I. A case report of early idiopathic portal hypertension. Pathol Res Pract 2001;197:759-63; discussion 765-7. [PMID: 11770020 DOI: 10.1078/0344-0338-00155] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
37 Krasinskas AM, Goldsmith JD, Burke A, Furth EE. Abnormal Intrahepatic Portal Vasculature in Native and Allograft Liver Biopsies: A Comparative Analysis. American Journal of Surgical Pathology 2005;29:1382-8. [DOI: 10.1097/01.pas.0000168508.70114.fd] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
38 Sato Y, Harada K, Sasaki M, Nakanuma Y. Altered intrahepatic microcirculation of idiopathic portal hypertension in relation to glutamine synthetase expression. Hepatol Res 2015;45:1323-30. [PMID: 25692330 DOI: 10.1111/hepr.12506] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
39 Bedossa P, Hytiroglou P, Yeh MM. Vascular Disorders. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 636-72. [DOI: 10.1016/b978-0-7020-6697-9.00011-x] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
40 Sawada S, Sato Y, Aoyama H, Harada K, Nakanuma Y. Pathological study of idiopathic portal hypertension with an emphasis on cause of death based on records of Annuals of Pathological Autopsy Cases in Japan. J Gastroenterol Hepatol 2007;22:204-9. [DOI: 10.1111/j.1440-1746.2006.04492.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
41 Seijo S, Lozano JJ, Alonso C, Reverter E, Miquel R, Abraldes JG, Martinez-Chantar ML, Garcia-Criado A, Berzigotti A, Castro A, Mato JM, Bosch J, Garcia-Pagan JC. Metabolomics discloses potential biomarkers for the noninvasive diagnosis of idiopathic portal hypertension. Am J Gastroenterol. 2013;108:926-932. [PMID: 23419380 DOI: 10.1038/ajg.2013.11] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
42 Sato Y, Sawada S, Kozaka K, Harada K, Sasaki M, Matsui O, Nakanuma Y. Significance of Enhanced Expression of Nitric Oxide Syntheses in Splenic Sinus Lining Cells in Altered Portal Hemodynamics of Idiopathic Portal Hypertension. Dig Dis Sci 2007;52:1987-94. [DOI: 10.1007/s10620-006-9146-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
43 Fiel MI, Schiano TD. Idiopathic noncirrhotic portal hypertension. Seminars in Diagnostic Pathology 2019;36:395-403. [DOI: 10.1053/j.semdp.2019.07.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
44 Inoue R, Nakazawa A, Tsukada N, Katoh Y, Nagao T, Nakanuma Y, Mukai K. POEMS syndrome with idiopathic portal hypertension: Autopsy case and review of the literature. Pathology International 2010;60:316-20. [DOI: 10.1111/j.1440-1827.2009.02513.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
45 Arora A, Sarin SK. Multimodality imaging of obliterative portal venopathy: what every radiologist should know. Br J Radiol 2015;88:20140653. [PMID: 25514699 DOI: 10.1259/bjr.20140653] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
46 Guido M, Sarcognato S, Sonzogni A, Lucà MG, Senzolo M, Fagiuoli S, Ferrarese A, Pizzi M, Giacomelli L, Colloredo G. Obliterative portal venopathy without portal hypertension: an underestimated condition. Liver Int 2016;36:454-60. [PMID: 26264219 DOI: 10.1111/liv.12936] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
47 Guido M, Sarcognato S, Sacchi D, Colloredo G. Pathology of idiopathic non-cirrhotic portal hypertension. Virchows Arch 2018;473:23-31. [DOI: 10.1007/s00428-018-2355-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
48 Aggarwal S, Fiel MI, Schiano TD. Obliterative Portal Venopathy: A Clinical and Histopathological Review. Dig Dis Sci 2013;58:2767-76. [DOI: 10.1007/s10620-013-2736-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
49 Kotani K, Kawabe J, Morikawa H, Akahoshi T, Hashizume M, Shiomi S. Comprehensive Screening of Gene Function and Networks by DNA Microarray Analysis in Japanese Patients with Idiopathic Portal Hypertension. Mediators Inflamm 2015;2015:349215. [PMID: 26549939 DOI: 10.1155/2015/349215] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
50 Kobayashi S, Ng CS, Kazama T, Madoff DC, Faria SC, Vauthey JN, Charnsangavej C. Hemodynamic and morphologic changes after portal vein embolization: differential effects in central and peripheral zones in the liver on multiphasic computed tomography. J Comput Assist Tomogr 2004;28:804-10. [PMID: 15538155 DOI: 10.1097/00004728-200411000-00013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
51 Kondo F. Benign nodular hepatocellular lesions caused by abnormal hepatic circulation: Etiological analysis and introduction of a new concept1. J Gastroenterol Hepatol 2001;16:1319-28. [DOI: 10.1046/j.1440-1746.2001.02576.x] [Cited by in Crossref: 138] [Cited by in F6Publishing: 87] [Article Influence: 6.9] [Reference Citation Analysis]